|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/00 | |
| A61K 38/13 | |||
| A61K 9/00 | |||
| A61K 47/32 | |||
| A61K 9/107 | |||
| A61K 31/436 | |||
| A61K 31/355 |
| (11) | Number of the document | 2197461 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08837729.6 |
| Date of filing the European patent application | 2008-10-08 | |
| (97) | Date of publication of the European application | 2010-06-23 |
| (45) | Date of publication and mention of the grant of the patent | 2018-02-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/079170 |
| Date | 2008-10-08 |
| (87) | Number | WO 2009/048929 |
| Date | 2009-04-16 |
| (30) | Number | Date | Country code |
| 997796 P | 2007-10-08 | US | |
| 992205 P | 2007-12-04 | US | |
| 38223 P | 2008-03-20 | US | |
| 99420 P | 2008-09-23 | US |
| (72) |
MITRA, Ashim K., US
VALAGALETI, Poonam R., US
NATESAN, Subramanian, IN
|
| (73) |
Aurinia Pharmaceuticals Inc.,
4464 Markham Street, Suite 1203, Victoria, BC V8Z 7X8,
CA
|
| (54) | OPHTHALMIC COMPOSITIONS COMPRISING CALCINEURIN INHIBITORS OR MTOR INHIBITORS |
| OPHTHALMIC COMPOSITIONS COMPRISING CALCINEURIN INHIBITORS OR MTOR INHIBITORS |